Denervation and β2-adrenoceptor-agonist administration on craniofacial bone density

Objective: β2-agonist medications are thought to have adverse effects on bone density. Surgical denervation and intramuscular β2-agonist injections appear to have opposing effects on skeletal muscles. The present study has been designed to assess the effects of denervation of the masseter, intramusc...

Full description

Bibliographic Details
Main Authors: Fitzpatrick Brendan, Woods Michael, Lynch Gordon, Manton David
Format: Article
Language:English
Published: Sciendo 2014-05-01
Series:Australasian Orthodontic Journal
Online Access:https://doi.org/10.2478/aoj-2014-0004
_version_ 1797752420955062272
author Fitzpatrick Brendan
Woods Michael
Lynch Gordon
Manton David
author_facet Fitzpatrick Brendan
Woods Michael
Lynch Gordon
Manton David
author_sort Fitzpatrick Brendan
collection DOAJ
description Objective: β2-agonist medications are thought to have adverse effects on bone density. Surgical denervation and intramuscular β2-agonist injections appear to have opposing effects on skeletal muscles. The present study has been designed to assess the effects of denervation of the masseter, intramuscular injection of a β2-agonist and the combination of both procedures, on bone density in the craniofacial skeleton in rats.
first_indexed 2024-03-12T17:04:10Z
format Article
id doaj.art-968e4e5f7ccd4533bacf667a1c4b469c
institution Directory Open Access Journal
issn 2207-7480
language English
last_indexed 2024-03-12T17:04:10Z
publishDate 2014-05-01
publisher Sciendo
record_format Article
series Australasian Orthodontic Journal
spelling doaj.art-968e4e5f7ccd4533bacf667a1c4b469c2023-08-07T06:57:55ZengSciendoAustralasian Orthodontic Journal2207-74802014-05-01301323810.2478/aoj-2014-0004Denervation and β2-adrenoceptor-agonist administration on craniofacial bone densityFitzpatrick Brendan0Woods Michael1Lynch Gordon2Manton David31Graduate Orthodontics, University of Melbourne, Melbourne, Australia2Oral and Maxillofacial Surgery, Royal Melbourne Hospital, Melbourne, Australia3Department of Physiology, University of Melbourne, Melbourne, Australia4Paediatric Dentistry, University of Melbourne, Melbourne, AustraliaObjective: β2-agonist medications are thought to have adverse effects on bone density. Surgical denervation and intramuscular β2-agonist injections appear to have opposing effects on skeletal muscles. The present study has been designed to assess the effects of denervation of the masseter, intramuscular injection of a β2-agonist and the combination of both procedures, on bone density in the craniofacial skeleton in rats.https://doi.org/10.2478/aoj-2014-0004
spellingShingle Fitzpatrick Brendan
Woods Michael
Lynch Gordon
Manton David
Denervation and β2-adrenoceptor-agonist administration on craniofacial bone density
Australasian Orthodontic Journal
title Denervation and β2-adrenoceptor-agonist administration on craniofacial bone density
title_full Denervation and β2-adrenoceptor-agonist administration on craniofacial bone density
title_fullStr Denervation and β2-adrenoceptor-agonist administration on craniofacial bone density
title_full_unstemmed Denervation and β2-adrenoceptor-agonist administration on craniofacial bone density
title_short Denervation and β2-adrenoceptor-agonist administration on craniofacial bone density
title_sort denervation and β2 adrenoceptor agonist administration on craniofacial bone density
url https://doi.org/10.2478/aoj-2014-0004
work_keys_str_mv AT fitzpatrickbrendan denervationandb2adrenoceptoragonistadministrationoncraniofacialbonedensity
AT woodsmichael denervationandb2adrenoceptoragonistadministrationoncraniofacialbonedensity
AT lynchgordon denervationandb2adrenoceptoragonistadministrationoncraniofacialbonedensity
AT mantondavid denervationandb2adrenoceptoragonistadministrationoncraniofacialbonedensity